Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06963463 · ClinicalTrials.gov registry record · NA

Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)

A NA study of Depression and Sleep, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
2
Study locations

NCT06963463 is a NA study of Depression and Sleep that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 90 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06963463, a NA study of Depression and Sleep, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to adapt a sleep intervention for individuals representative of all demographic groups, including those who are at the highest risk for suicidal behavior. Sleep difficulties are a promising target for youth with suicidal thoughts and behavior to focus on as a prevention measure. We aim to increase intervention acceptability and impact by adapting it for the adolescent populations at highest risk for suicidal thoughts and behavior. The research project will compare Transdiagnostic Sleep and Circadian Intervention (TranS-C), an evidence based, modularized intervention that targets a range of sleep difficulties to a treatment as usual or control condition including providing weekly sleep feedback reports from data entered into a daily sleep diary and from wearing a sleep sensing, actigraphy watch. Participants in both conditions (TranS-C vs. Sleep Feedback) will wear an actigraphy sleep watch that monitors sleep, and complete daily sleep diaries via smartphone or email. Participants in the TranS-C condition will also wear bright light (BL) and blue blocking glasses each day as well as attend weekly or biweekly sessions with a Sleep Therapist. The sleep therapist will review sleep feedback during sessions.

Interventions

  • BEHAVIORAL TranS-C
  • BEHAVIORAL Sleep Feedback

Study Locations (2)

Pennsylvania

  • Childrens Hospital of Philadelphia - Philadelphia
  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2025-05-06
Est. Completion 2027-07-31
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT06963463

The ClinicalTrials.gov registry entry for NCT06963463 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which TranS-C is the first listed.

NCT06963463 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06963463 about?

NCT06963463 is a clinical study titled "Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)". The goal of this clinical trial is to adapt a sleep intervention for individuals representative of all demographic groups, including those who are at the highest risk for suicidal behavior. Sleep difficulties are a promising target for youth with suicidal thoughts and behavior to focus on as a preve...

What is the current status of trial NCT06963463?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-05-06. Estimated completion is 2027-07-31.

What conditions does trial NCT06963463 study?

This clinical trial studies the following conditions: Depression, Sleep, Suicide, Sleep Disturbance.

What interventions are being tested in trial NCT06963463?

The interventions under investigation include: TranS-C (BEHAVIORAL), Sleep Feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT06963463?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06963463 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.